GSK halts US sales of its blood cancer drug Blenrep
(Natural News) British pharmaceutical firm GSK announced that it will stop selling its blood cancer drug Blenrep in the United States. The company announced on Nov. 22 that it has begun the process to withdraw the drug’s marketing authorization in the country. It clarified, however, that trials for the drug would continue and that some…
NaturalNews.comRead More
BREAKING NEWS
- News Quiz: April 19, 2024
- Albanian “King Of Instagram” Used Platform To Tell Followers How To Sneak Into Britain, Join The Drug Trade
- What Happened To Bitcoin?
- Risk of Bird Flu Spreading to Humans Is Great Concern: World Health Organization
- Chicago City Council Delays Vote on $70 Million Funding for Illegal Immigrants
- Blaze News investigates: A child was removed by a red state following complaints over Christian views deemed sickening
- Friday Morning Minute
- Elon Musk Calls NPR CEO ‘One of the Worst Human Beings in America,’ Announces Campaign for 1st Amendment
- Swiss Watch Exports Crash In China & Hong Kong
- Weak EV Market Dragged Down European Car Sales In March
Leave a Reply